Five patients in this study had BRAF mutations (3 with V600E mutations and 2 with non-V600E mutations), and previous studies reported BRAF mutations in EGFR-mutated NSCLC with resistance to EGFR-TKIs [33, 34]. Here, EGFR is linked to non-small cell lung carcinoma.